Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Other Working Capital Changes (2020 - 2025)

Historic Other Working Capital Changes for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to $188000.0.

  • SOPHiA GENETICS's Other Working Capital Changes rose 21463.41% to $188000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$911000.0, marking a year-over-year decrease of 20630.11%. This contributed to the annual value of -$1.2 million for FY2024, which is 18414.55% down from last year.
  • According to the latest figures from Q3 2025, SOPHiA GENETICS's Other Working Capital Changes is $188000.0, which was up 21463.41% from $247000.0 recorded in Q2 2025.
  • Over the past 5 years, SOPHiA GENETICS's Other Working Capital Changes peaked at $3.2 million during Q4 2021, and registered a low of -$4.4 million during Q3 2021.
  • Moreover, its 5-year median value for Other Working Capital Changes was $129000.0 (2023), whereas its average is -$136684.2.
  • In the last 5 years, SOPHiA GENETICS's Other Working Capital Changes plummeted by 154918.57% in 2021 and then soared by 32248.06% in 2024.
  • Over the past 5 years, SOPHiA GENETICS's Other Working Capital Changes (Quarter) stood at $3.2 million in 2021, then plummeted by 148.04% to -$1.5 million in 2022, then soared by 139.88% to $611000.0 in 2023, then tumbled by 329.62% to -$1.4 million in 2024, then surged by 113.4% to $188000.0 in 2025.
  • Its Other Working Capital Changes stands at $188000.0 for Q3 2025, versus $247000.0 for Q2 2025 and $57000.0 for Q1 2025.